A nicotinic drug approved for smoking cessation significantly improved the walking ability of patients suffering from an inherited form of ataxia, reports a new clinical study led by University of South Florida researchers.
Recent PostsMonday, October 13, 2014
The University of Florida’s Multi-functional Integrated System Technology (MIST) Center will play a leading role in researching the next generation of “smart” electronics funded by a National Science Foundation program that combines federal money with industry investments in strategic research. ..Read More ⇒Sunday, October 12, 2014
VGTI Florida, a leading, non-profit biomedical research institute, announced the launch of its Center for Diseases of Aging (“CDA”), a major initiative to accelerate the discovery and advancement of novel, best-in-class healthcare interventions for the prevention and treatment of diseases commonly associated with aging. ..Read More ⇒Friday, October 10, 2014
Researchers at the University of Central Florida set a new record in funded research in FY14, receiving $145.6 million, 30 percent more than the previous year. The funding totals reflect successful collaborations with industry, a record total for federal defense grants and continued growth in commercialization and innovation activity. ..Read More ⇒Thursday, October 09, 2014
A team of scientists led by Sanford-Burnham’s Ranjan J Perera, Ph.D., has identified a set of RNA molecules that are detectable in tissue samples and urine of prostate cancer patients, but not in normal healthy individuals. The study sets the stage for the development of more-sensitive and specific non-invasive tests for prostate cancer than those currently available, which could result in fewer unnecessary prostate biopsies with less treatment-related morbidity, according to a new study in The Journal of Molecular Diagnostics. ..Read More ⇒Wednesday, October 08, 2014
The University of Florida announced today the formation of the UF Diabetes Institute, a collaboration of dozens of researchers campuswide all focused on forging advances in treatment for a disease that afflicts an estimated 29.1 million Americans and 1 in 10 Floridians. ..Read More ⇒
Tagseconomy Florida Atlantic University AxoGen Jackson Lab University of North Florida neuroscience Nanotheraputics engineering biotechnology IHMC health care marine astronomy agriculture Torrey Pines Institute nanotechnology business FL Institute for Commercialization of Public Research policy energy GrowFL Florida Hospital accreditation Florida Institute of Technology consumers University of Florida University of Central Florida physics aging technology conference / event photonics education bioscience ICFO clean energy gender research policy Embry-Riddle AGTC partnerships Moffitt Cancer Center sustainability green technology Banyan Biomarkers HIV/AIDS stem cell life science Florida Trend society/culture Max Planck innovation BioFlorida Univeristy of South Florida Florida Gulf Coast Univ. grants environment materials science Nova Southeastern Univ. robotics commercialization University of Miami research ecology sciences Draper VGTI medical awards cancer accolades magnets computer science children health Enterprise Florida Florida Power & Light biomedical animals University of West Florida Florida State University accounting Sanford-Burnham Scripps Research Institute aerospace Florida International Univ. FAMU